Wednesday 20 August 2014

Cadila Update by Epic Research

Cadila Healthcare

Cadila has received the final approval from the USFDA to market Acyclovir Tablets in the strengths of 400 mg and 800 mg. The drug falls under the anti-viral segment. The estimated sales in 2014 for Acyclovir Tablets is $55.8 million, as per IMS.



Real Time News & Trading Trends Keep Liking #EpicResearch




FacebookTwitterYouTubePinterestLinkedin - Google+



For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH


0 comments:

Post a Comment

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Online Project management